Remove Compliance Remove FDA Remove Records Management
article thumbnail

eQMS Explained: Your Complete Guide to Electronic Quality Management Systems

Dot Compliance

Electronic Quality Management Systems (eQMS) help meet these demands by streamlining processes, helping to meet compliance, and supporting continuous improvement across the enterprise. Training Management Training plan creation: Develop and manage training plans that align with organizational needs and regulatory requirements.

article thumbnail

How to Choose the Best Quality Management Solution (QMS) for Life Science Manufacturers

Dot Compliance

All while keeping in mind that compliance to regulations and global standards are non-negotiable, especially in the highly regulated life science and biotech industries. Here are key points to consider when selecting a QMS solution to support your company’s compliance and growth.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

QMS 101: Quality Management System Guide

Dot Compliance

What is Quality Management System (QMS)? How Do Quality Management Systems Help Businesses Increase Profitability? Quality Management System Examples 4. Dot Compliance eQMS Essential Elements 5. Ensuring Compliance with ISO 9001, EU MDR, FDA & More 6. Quality Management System Development 7.

FDA 52
article thumbnail

SQA Regulatory Surveillance Summary for May and June 2024

SQA

Level 2: When a simplified analysis of the EFRA inspection report is performed to evaluate compliance with the GMP requirements and may be adopted unilaterally by ANVISA. The classification criteria include: Serious deficiencies: Typically linked to non-compliance with critical items. Major deficiencies: Associated with major items.

FDA 52
article thumbnail

SQA Regulatory Surveillance Summary for May and June 2024

SQA

Level 2: When a simplified analysis of the EFRA inspection report is performed to evaluate compliance with the GMP requirements and may be adopted unilaterally by ANVISA. The classification criteria include: Serious deficiencies: Typically linked to non-compliance with critical items. Major deficiencies: Associated with major items.

FDA 40
article thumbnail

SQA Regulatory Surveillance Summary for January and February 2024

SQA

Additional findings included concerns with respect to document control, records management, and lack of compliance with Standard Operating Procedures (SOPs). FDA has prepared a draft document entitled Food and Drug Administrations Draft Report and Plan on Best Practices for Guidance. PDA Technical Report No.

FDA 40